FDA warns against combination of malaria drug and Gilead's remdesivir
The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences' experimental COVID-19 drug, remdesivir. [Source]
Publication Date:Origin: reuters.com
Category: topNews
Topics: remdesivir, malaria, combination, against, COVID-19, experimental, Sciences', Gilead, chloroquine, hydroxychloroquine, administering, providers, healthcare, warning, issued, Administration, Gilead's, warns
